NH
National Health Investors, Inc.
NHI · NYSE
$70.96 -1.32% (-$0.95)
1M -5.97%
Market Cap $3.49B
P/E Ratio 20.90x
Div. Yield 5.12%
ROE 10.96%
Bulios Fair Price
$100.97
42.3% upside
Current Price
$70.96
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NHI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
78 /100
Cheap P/B 2.22x
P/FCF 14.79x
P/S 8.04x
Growth
86 /100
Growing Rev. growth 10.81%
FCF growth 6.82%
Book val. growth 6.20%
Profitability
100 /100
Strong Net margin 38.47%
Op. margin 45.45%
FCF margin 54.37%
Quality
80 /100
Excellent ROE 10.96%
ROA 5.63%
Asset turnover 0.15x
Debt
79 /100
Low Current ratio 0.59x
Int. coverage 5.05x
Debt/Assets 0.43x
Stability
70 /100
Stable Rev. volatility 5.38%
EPS volatility 297.62%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NHI
Online
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
D. Eric Mendelsohn
Employees
32
Headquarters
Murfreesboro
Upcoming events
30 SEP
Ex-Dividend
Ex-dividend date
05 NOV
Earnings
Upcoming earnings report
06 NOV
Dividend Payment
Payment date